Financial Toxicity Considerations in Breast Reconstruction: Recommendations for Research and Practice.
作者信息
Kinzer Hannah, Lee Clara N, Cooksey Krista, Myckatyn Terence, Olsen Margaret A, Foraker Randi, Johnson Anna Rose, Politi Mary C
机构信息
Washington University in St Louis, School of Medicine, St. Louis, Missouri.
University of North Carolina-Chapel Hill, School of Medicine, Chapel Hill, North Carolina.
出版信息
Womens Health Issues. 2024 Mar-Apr;34(2):107-114. doi: 10.1016/j.whi.2024.01.005. Epub 2024 Feb 26.
Abstract
摘要
相似文献
1
Financial Toxicity Considerations in Breast Reconstruction: Recommendations for Research and Practice.乳房重建中的经济毒性考量：研究与实践建议
Womens Health Issues. 2024 Mar-Apr;34(2):107-114. doi: 10.1016/j.whi.2024.01.005. Epub 2024 Feb 26.
2
Understanding the Relationship between Breast Reconstruction Subtype and Risk of Financial Toxicity: A Single-Institution Pilot Study.理解乳房重建亚型与财务毒性风险之间的关系：单机构试点研究。
Plast Reconstr Surg. 2021 Jul 1;148(1):1e-11e. doi: 10.1097/PRS.0000000000008015.
3
Impact of High-Deductible Health Plans on Breast Reconstruction: Considerations for Financial Toxicity.高自付额健康计划对乳房重建的影响：财务毒性的考虑。
Plast Reconstr Surg. 2023 Feb 1;151(2):245-253. doi: 10.1097/PRS.0000000000009823. Epub 2022 Nov 8.
4
ASO Author Reflections: Characterizing Financial Toxicity in Post-mastectomy Breast Reconstruction: A Need for Additional Perspectives.美国整形外科学会作者反思：乳房切除术后乳房重建中财务毒性的特征分析：需要更多视角。
Ann Surg Oncol. 2022 Jan;29(1):545-546. doi: 10.1245/s10434-021-10710-x. Epub 2021 Sep 3.
5
Financial Toxicity Following Post-Mastectomy Reconstruction: Consideration for a Novel Outcome Measure.乳房切除术后重建后的经济毒性：对一种新型结局指标的考量
Ann Surg Oncol. 2022 Jan;29(1):25-27. doi: 10.1245/s10434-021-10792-7. Epub 2021 Sep 15.
6
Financial Toxicity in Breast Reconstruction: A National Survey of Women Who have Undergone Breast Reconstruction After Mastectomy.乳房重建中的经济毒性：一项针对乳房切除术后接受乳房重建女性的全国性调查。
Ann Surg Oncol. 2022 Jan;29(1):535-544. doi: 10.1245/s10434-021-10708-5. Epub 2021 Sep 3.
7
Self-Reported Risk Factors for Financial Distress and Attitudes Regarding Cost Discussions in Cancer Care: A Single-Institution Cross-Sectional Pilot Study of Breast Reconstruction Recipients.自我报告的财务困境风险因素和对癌症护理中成本讨论的态度：一项针对乳房重建接受者的单机构横断面试点研究。
Plast Reconstr Surg. 2021 Apr 1;147(4):587e-595e. doi: 10.1097/PRS.0000000000007703.
8
The Financial Impact of S Code Termination for Autologous Breast Reconstruction: Considerations for Patient Access.自体乳房重建中S代码终止的财务影响：患者可及性考量
Plast Reconstr Surg. 2024 Mar 1;153(3):658e-660e. doi: 10.1097/PRS.0000000000010983. Epub 2023 Aug 11.
9
Comparisons of resource costs and success rates between immediate and delayed breast reconstruction using DIEP or SIEA flaps under a well-controlled clinical trial.在一项严格控制的临床试验中，对使用腹壁下深动脉（DIEP）皮瓣或腹壁浅动脉（SIEA）皮瓣进行即刻和延迟乳房重建的资源成本和成功率进行比较。
Plast Reconstr Surg. 2006 Jun;117(7):2139-42; discussion 2143-4. doi: 10.1097/01.prs.0000218286.64522.15.
10
A comparison of patient-centered economic and clinical outcomes of post-mastectomy breast reconstruction between obese and non-obese patients.肥胖与非肥胖患者乳房切除术后乳房重建以患者为中心的经济和临床结果比较。
Breast. 2016 Dec;30:118-124. doi: 10.1016/j.breast.2016.09.004. Epub 2016 Sep 30.
引用本文的文献
1
Logistic and time burdens reported by gynecologic and breast cancer survivors.妇科和乳腺癌幸存者报告的后勤和时间负担。
BMC Womens Health. 2025 Jun 2;25(1):273. doi: 10.1186/s12905-025-03826-9.
本文引用的文献
1
Cost communication in cosmetic and reconstructive breast surgery: Public perceptions in the United States.美容与重建乳房外科中的成本沟通：美国公众的看法。
J Plast Reconstr Aesthet Surg. 2023 Aug;83:126-133. doi: 10.1016/j.bjps.2023.04.031. Epub 2023 Apr 18.
2
The Insurance Landscape for Implant- and Autologous-based Breast Reconstruction in the United States.美国基于植入物和自体组织的乳房重建的保险情况。
Plast Reconstr Surg Glob Open. 2023 Feb 17;11(2):e4818. doi: 10.1097/GOX.0000000000004818. eCollection 2023 Feb.
3
Racial Disparities in the Cost of Unplanned Hospitalizations after Breast Reconstruction.种族差异对乳房重建术后非计划性住院费用的影响。
Plast Reconstr Surg. 2023 Aug 1;152(2):281-290. doi: 10.1097/PRS.0000000000010200. Epub 2023 Jul 27.
4
Impact of High-Deductible Health Plans on Breast Reconstruction: Considerations for Financial Toxicity.高自付额健康计划对乳房重建的影响：财务毒性的考虑。
Plast Reconstr Surg. 2023 Feb 1;151(2):245-253. doi: 10.1097/PRS.0000000000009823. Epub 2022 Nov 8.
5
Discussing Cost and Value in Patient Decision Aids and Shared Decision Making: A Call to Action.探讨患者决策辅助工具和共同决策中的成本与价值：行动呼吁。
MDM Policy Pract. 2023 Jan 10;8(1):23814683221148651. doi: 10.1177/23814683221148651. eCollection 2023 Jan-Jun.
6
Commercial Price Variation for Breast Reconstruction in the Era of Price Transparency.商业价格变化对乳房重建的影响——价格透明时代。
JAMA Surg. 2023 Feb 1;158(2):152-160. doi: 10.1001/jamasurg.2022.6402.
7
Assessing Patient-Reported Financial Hardship in Patients With Cancer in Routine Clinical Care.评估常规临床护理中癌症患者的患者报告经济困难。
JCO Oncol Pract. 2022 Nov;18(11):e1839-e1853. doi: 10.1200/OP.22.00276. Epub 2022 Sep 27.
8
ABLE to support patient financial capacity: A qualitative analysis of cost conversations in clinical encounters.能够支持患者的经济能力：临床就诊中费用对话的定性分析。
Patient Educ Couns. 2022 Nov;105(11):3249-3258. doi: 10.1016/j.pec.2022.07.016. Epub 2022 Jul 25.
9
Stalled at the intersection: insurance status and disparities in post-mastectomy breast reconstruction.卡在十字路口：保险状况与乳房再造术后差异。
Breast Cancer Res Treat. 2022 Jul;194(2):327-335. doi: 10.1007/s10549-022-06639-8. Epub 2022 Jun 14.
10
The Cancer Financial Experience (CAFÉ) study: randomized controlled trial of a financial navigation intervention to address cancer-related financial hardship.癌症财务体验（CAFÉ）研究：一项针对癌症相关经济困难的财务导航干预措施的随机对照试验。
Trials. 2022 May 13;23(1):402. doi: 10.1186/s13063-022-06344-3.
Zotero 插件